✦ LIBER ✦

Nicotine and Behavioral Markers of Risk for Schizophrenia: A Double-Blind, Placebo-Controlled, Cross-Over Study

✍ Scribed by Lana Dépatie; Gillian A. O'Driscoll; Anne-Lise V. Holahan; Victoria Atkinson; Joseph X. Thavundayil; N.Ng Ying Kin; Samarthji Lal

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Lorazepam for chronic catatonia: a rando

✍ G. S. Ungvari; Helen F. K. Chiu; Lok Yee Chow; Benjamin S. T. Lau; Wai Kwong Tan 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 74 KB

A double-blind placebo-controlled cross

✍ S.H. Fatemi; J.M. Stary; D.K. Hatsukami; S.E. Murphy 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 94 KB

Migraine Prophylaxis with Salmon Calcito

✍ Carlo Gennari; M. Silvio Chierichetti; Stefano Gonnelli; Claudio Vibelli; Mario 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB

Cyclandelate in diabetic neuropathy. A d

✍ J. J. Hemans; B. Drukarch; I. Matthaei; G. A. Liff; F. W. Bertelsmann; R. L. M. 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB

P.6.063 Lorazepam for stupor and mutism:

✍ H. Wetzel; C.J. Klawe; M.J. Müller; J. Wiesner; O. Benkert 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 275 KB

Differential effects of escitalopram on

✍ Barbara Drueke; Julia Baetz; Maren Boecker; Olaf Moeller; Christoph Hiemke; Gerd 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 229 KB